PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Replacing brain immune cells in mice slows neurodegeneration in Stanford Medicine study

Replacing brain cell slows neurodegeneration

2025-08-06
(Press-News.org) Tay-Sachs and Sandhoff diseases, genetic disorders affecting the brain, have no effective treatment and are typically fatal within the first years of life. Scientists have reasoned that replacing the affected cells with those that are genetically healthy could slow or halt the neural degeneration that causes the symptoms. But the approach has been plagued with problems, including poor engraftment in the brain and a graft-versus-host response in which transplanted cells attack healthy tissue.

Now researchers at Stanford Medicine have developed a way to replace more than half of the most severely affected cells, called microglia, with non-genetically matched precursor cells in mice. In animals with a form of Sandhoff disease, the approach helped them live longer and dramatically reduced behavioral and motor symptoms of the disease.

If the approach can be translated for use in humans, it could offer a glimmer of hope for the families of children with these rare diseases. Because it’s not necessary to use a patient’s own cells, the approach might one day offer the possibility of an “off the shelf” therapy that would be quicker and cheaper than bespoke genetic engineering for each case.

“Using a specific sequence of steps, we were able to achieve nearly 100% incorporation of genetically healthy cells in the brains of the mice while avoiding both rejection and graft-versus-host disease,” said professor of pathology Marius Wernig, MD, PhD. “This is vastly better than previous approaches. Furthermore, we were stunned at how well this therapy worked. The mice survived for the duration of the experiment, showed improved motor function and regained normal mouse behaviors like exploring open spaces. The difference between treated and control animals was dramatic.”

Wernig, a program leader in Stanford’s Institute for Stem Cell Biology and Regenerative Medicine, is the senior author of the research, to be published on Aug. 6 in Nature. Former postdoctoral scholar Marius Mader, MD, is the lead author of the study.

Devastating inherited diseases

Tay-Sachs, which affects about 1 in every 3,700 newborns of Ashkenazi Jewish descent, and Sandhoff, which is far less prevalent, belong to an inherited class of diseases called lysosomal storage disorders. Although rare, many are devastating, particularly those that primarily affect the brain. Affected infants often develop normally for the first weeks or months of life but rapidly regress as their neurons degenerate.

Babies born with these disorders have mutations in genes for enzymes critical to the function of lysosomes — cellular recycling compartments responsible for breaking down no longer needed proteins, carbohydrates and fat molecules called lipids into smaller building blocks for reuse. If lysosomes are unable to function, these molecules accumulate to dangerous levels in the cell.

But there is a mystery.

“Although the symptoms of these diseases are due to the degeneration of neurons, the levels of lysosomal enzymes in neighboring immune cells called microglia are sometimes a thousand-fold higher than in neurons,” said Wernig, the Dr. Salim and Mrs. Mary Shelby Faculty Scholar. So, why is it that the neurons are dying if the microglia are more severely affected?

One of the many functions of microglia is to engulf and break down dead cells or pathogens in the brain. “They are like professional cleaners,” Wernig said. “Therefore, they have a much greater need for these degradative enzymes than other cells.” The researchers wondered if restoring lysosomal enzymes to the microglia could somehow help the neurons.

Past attempts to correct the genetic deficiency in the microglia in lysosomal storage disorders involved a hematopoietic stem cell transplant (often referred to as a bone marrow transplant) to reboot the patient’s immune system, including the microglia in the brain. In this type of transplant, the person’s own immune system is first eliminated with drugs (a step called preconditioning), then genetically healthy immune cell precursors are introduced intravenously in the hope that they will establish themselves in the patient and begin making the missing protein.

But getting the healthy cells into the brain is difficult because the body tightly restricts access to the central nervous system. Other possible complications of a bodywide transplant include the elimination of donor cells by any remaining immune cells or, conversely, the life-threatening graft-versus-host disease.

Research from Wernig’s laboratory in 2022 showed it’s possible to achieve 90% engraftment of donor cells by wiping out the recipient animal’s immune system and treating them with a drug to kill off existing microglia, giving the donated hematopoietic stem cells a competitive growth advantage. But the technique still required toxic preconditioning and relied on genetically identical donor cells to prevent graft-versus-host disease.

“A hematopoietic stem cell transplant is a rough procedure to go through,” Wernig said. “It’s not something you want to do to your patients unless there’s no other option.”

A targeted transplant procedure

In the current study, Mader and Wernig tested whether they could develop a brain-specific transplant procedure that would avoid the toxic preconditioning and bodywide effects of a hematopoietic stem cell transplant. To that end, they coupled the microglia-depleting drug treatment with irradiation of the brain to create space for the new cells to occupy. They then injected microglia precursor cells — a more specialized subset of hematopoietic stem cells — from a non-genetically matched donor animal into the brain. Finally, they administered two drugs to block the activation of immune cells from elsewhere in the body that would otherwise kill the unmatched donated cells.

This delicate tango of steps resulted in efficient engraftment of the donated cells, which nestled into the brain and developed into microglia without migrating to the rest of the body or being attacked by the recipient animal’s immune system.

The cells’ engraftment was lasting: More than 85% of the microglial cells in the brain were derived from the donated cells eight months after transplantation. Untreated mice with a version of Sandhoff disease lived a median of 135 days and no animal lived beyond 155 days. In contrast, five of the animals treated with the brain-specific microglia transplantation therapy lived up to 250 days, when the experiment was terminated.

Although the long-lived treated mice eventually developed hind leg paralysis, they displayed normal exploration behaviors in a large open pen and greater muscle strength and coordination than control animals.

A closer investigation of the relationship between the donated microglia and their neuronal neighbors revealed something intriguing: The missing lysosomal enzyme now being made by the microglia could also be found in the animals’ native neurons. Although the reason is not yet known, Wernig and Mader suspect the microglia are packaging and secreting the enzyme into the space between cells, where it is imported into the neurons.

“This could be an important, unrecognized role for microglia: to supply lysosomal factors to the environment including neurons,” Wernig said.

The researchers are optimistic their approach could be translated to humans because each individual step — irradiation, administering drugs used to wipe out existing microglia and applying drugs to prevent immune attack of the donated cells — is already used to treat other conditions.

“We’ve solved three big problems with this study,” Wernig said. “We achieved efficient brain-restricted transplantation without systemic toxic preconditioning, we were able to use non-genetically matched cells that don’t require genetic engineering to make the missing lysosomal enzyme, and we avoided immune rejection and graft-versus-host disease. We’re very happy.”

The researchers also believe the therapy could be widely applicable.

“It’s possible that these lysosomal storage diseases are just an accelerated version of much more common neurodegenerative diseases like Alzheimer’s or Parkinson’s,” Wernig said. “If so, this therapy could be very relevant not just for a small subset of children, but for many, many more people.”

The study was funded by the California Institute for Regenerative Medicine, the German Research Foundation, the New York Stem Cell Foundation, the Robert J. Kleberg Jr. and Helen C. Kleberg Foundation, and the Wu Tsai Neurosciences Institute.

 

 

# # #

 

About Stanford Medicine

Stanford Medicine is an integrated academic health system comprising the Stanford School of Medicine and adult and pediatric health care delivery systems. Together, they harness the full potential of biomedicine through collaborative research, education and clinical care for patients. For more information, please visit med.stanford.edu.

END



ELSE PRESS RELEASES FROM THIS DATE:

Early heartbeats direct the heart’s own development and growth

2025-08-06
Francis Crick Institute press release Under strict embargo: 16:00hrs BST Wednesday 6 August 2025 Peer reviewed Experimental study Animals (zebrafish) Early heartbeats direct the heart’s own development and growth Researchers at the Francis Crick Institute have discovered that the heart’s own contractions trigger biological signals that guide the formation of a functional beating heart. Their study in zebrafish highlights the heart’s ability to remodel and adapt to physiological demands and could also reveal what goes wrong during congenital ...

Changes to El Niño occurrence causing widespread tropical insect and spider declines

2025-08-06
Arthropods, including insects and spiders, make up the vast majority of animal species on the planet. Despite their small size they are irreplaceable contributors to the health of natural habitats, as well as vital food sources for birds and other larger animals. But, arthropods may be declining globally. There is some evidence to support reduced numbers of species in temperate regions of the Northen Hemisphere. In the tropics, however, evidence for arthropod declines has so far been limited. A recent international collaboration of scientists has attempted to find this missing evidence, with the findings published in Nature. The ...

Nanophotonics: An ultrafast light switch

2025-08-06
In nanophotonics, tiny structures are used to control light at the nanoscale and render it useful for technological applications. A key element here is optical resonators, which trap and amplify light of a certain color (wavelength). Previous methods of controlling these resonances were more like a dimmer switch: You could weaken the resonance or slightly shift its color. However, genuine on-and-off switching was not possible, as the resonators always remain fundamentally coupled with the light. A team led by Andreas Tittl, Professor of Experimental Physics at LMU, has now achieved precisely this breakthrough together with partners from Monash ...

Human instruction with artificial intelligence guidance provided best results in neurosurgical training

2025-08-06
Artificial intelligence (AI) is becoming a powerful new tool in training and education, including in the field of neurosurgery. Yet a new study suggests that AI tutoring provides better results when paired with human instruction. Researchers at the Neurosurgical Simulation and Artificial Intelligence Learning Centre at The Neuro (Montreal Neurological Institute-Hospital) of McGill University are studying how AI and virtual reality (VR) can improve the training and performance of brain surgeons. They simulate brain surgeries using VR, monitor ...

IHME’s 2025 Roux Prize awarded to rural health equity advocate – recognized for advancing access to oral health care in Nigeria

2025-08-06
IHME’s 2025 Roux Prize Awarded to Rural Health Equity Advocate – Recognized for Advancing Access to Oral Health Care in Nigeria  Dr. Adekemi Adeniyan will receive a $100,000 award for pioneering innovative, data-driven solutions to tackle oral health disparities in underserved communities.  Dr. Adekemi Adeniyan, Executive Director of the Dentalcare Foundation, rural dentist, and advocate for oral health advancement in Nigeria, has been named the Institute for Health Metrics and Evaluation’s ...

Archaeologists find oldest evidence of humans on ‘Hobbit’s’ island neighbor – who they were remains a mystery

2025-08-06
Recent findings, made by Griffith University researchers, show that early hominins made a major deep-sea crossing to reach the Indonesian island of Sulawesi much earlier than previously established, based on the discovery of stone tools dating to at least 1.04 million years ago at the Early Pleistocene (or ‘Ice Age’) site of Calio. Budianto Hakim from the National Research and Innovation Agency of Indonesia (BRIN) and Professor Adam Brumm from the Australian Research Centre for Human Evolution at Griffith University led the ...

Novel microwave dielectric ceramics enable high-performance 5G/6G communication devices

2025-08-06
With the global rollout of 5G networks and the onset of 6G research, the need for advanced materials that enable faster and more reliable wireless communication has never been greater. Microwave dielectric ceramics, key components in devices like resonators, filters, and antennas, must meet strict criteria: low signal delay, low loss, and stable performance across temperatures.   A research team from Guilin University of Technology in China has risen to this challenge by developing a novel garnet-type ceramic, YMAG. Synthesized using a solid-state reaction method, YMAG exhibits impressive microwave properties: a permittivity (εr) of 9.86, a quality factor ...

Revealed: New vaccine target to block malaria transmission

2025-08-06
Australian researchers have visualised a key protein complex in malaria parasites for the first time, uncovering a new target for next-generation vaccines that could help stop the disease from spreading. Using cutting-edge cryo-electron microscopy, the research team from WEHI captured the first detailed structure of a protein complex essential for malaria parasite fertilisation. The discovery published in Science has led to the development of a promising new mRNA vaccine candidate that stops the malaria parasite from reproducing inside mosquitoes, breaking the cycle of transmission ...

Air purifiers may reduce heart risks for people exposed to traffic pollution

2025-08-06
WASHINGTON (August 6, 2025) — Using portable high-efficiency particulate air (HEPA) purifiers at home can significantly lower systolic blood pressure (SBP) in adults with elevated baseline readings — even in areas with relatively low overall air pollution levels, according to a study published today in JACC, the flagship journal of the American College of Cardiology.   Particulate matter (PM) is a major contributor to air pollution and is strongly associated with cardiovascular disease (CVD). People ...

Effective therapy for MDS is vastly underused, especially in female and non-white patients

2025-08-06
(WASHINGTON – August 6, 2025) – Most patients with high-risk myelodysplastic syndromes (MDS) do not receive guideline-recommended treatment with hypomethylating agents (HMAs), according to results published in Blood Neoplasia. The findings suggest that underuse of these drugs may help explain why MDS outcomes have not improved over the past two decades since these life-extending medications became available.   The study is the largest analysis of MDS treatment patterns in the United States to date and the most comprehensive study of real-world use of HMAs, which are highly effective in improving outcomes. HMAs are the best available ...

LAST 30 PRESS RELEASES:

Some young suns align with their planet-forming disks, others are born tilted

Neighbors matter: Community cohesion boosts disaster resilience, Texas A&M study finds

Virtual reality shows promise in easing stress for cardiac patients, UCLA Health study finds

MBARI researchers deploy new imaging system to study the movement of deep-sea octopus

Scrambled RNA nudges millions of people towards type-2 diabetes

Big heart, acute senses key to explosive radiation of early fishes

Getting sticky: The highest-performing underwater adhesive hydrogel polymer

The health impact of wildfires in Los Angeles County and Maui

Replacing brain immune cells in mice slows neurodegeneration in Stanford Medicine study

Early heartbeats direct the heart’s own development and growth

Changes to El Niño occurrence causing widespread tropical insect and spider declines

Nanophotonics: An ultrafast light switch

Human instruction with artificial intelligence guidance provided best results in neurosurgical training

IHME’s 2025 Roux Prize awarded to rural health equity advocate – recognized for advancing access to oral health care in Nigeria

Archaeologists find oldest evidence of humans on ‘Hobbit’s’ island neighbor – who they were remains a mystery

Novel microwave dielectric ceramics enable high-performance 5G/6G communication devices

Revealed: New vaccine target to block malaria transmission

Air purifiers may reduce heart risks for people exposed to traffic pollution

Effective therapy for MDS is vastly underused, especially in female and non-white patients

Genetic rescue of endangered species may risk bad mutations slipping through

480 macrofungal species discovered in southeast Xizang, China: 8 new species, 115 edible, and 53 poisonous fungi

New study on hope among U.S. youth reveals key to safer schools this fall

AI chatbots can run with medical misinformation, study finds, highlighting the need for stronger safeguards

Nanoparticles for rheumatoid arthritis prevention, flare control

Small-world networks can mitigate ESG controversies for multinationals, suggests new study

Yonsei University researchers directly measure quantum metric tensor in real material

TEER associated with improved survival in the elderly patients with AFMR

Excessive screen time among youth may pose heart health risks

Pure quantum state without the need for cooling

NHS Active 10 walking tracker users are more active after using the app

[Press-News.org] Replacing brain immune cells in mice slows neurodegeneration in Stanford Medicine study
Replacing brain cell slows neurodegeneration